Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
4
×
biotech
boston blog main
boston top stories
fda
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
480 biomedical
abbvie
acorda therapeutics
aimmune therapeutics
allergy
amgen
ampyra
anaphylaxis
andrew oxtoby
apokyn
apomorphine
arsenal medical
bob langer
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
chronic rhinosinusitis
covid-19
dalfampridine
daniel edelman
deals
detroit blog main
detroit top stories
drug delivery
drugs
duopa
What
late
4
×
approved
drug
fda
new
approval
developed
friday
therapeutics
treat
won
acorda
agency
aimmune
allergy
announced
awarded
biotech
class
company
cope
debut
decision
developing
disease
eli
episodes
gets
headache
help
immunotherapy
ipo
lilly
looms
lyra
markets
marks
meant
medications
medicines
Language
unset
Current search:
late
×
" national blog main "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines